Perceptive Advisors as of June 30, 2023
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 93 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amicus Therapeutics (FOLD) | 10.4 | $347M | 28M | 12.56 | |
| Cerevel Therapeutics Hldng I (CERE) | 9.4 | $315M | 9.9M | 31.79 | |
| Lianbio Sponsored Ads (LIANY) | 3.9 | $131M | 58M | 2.28 | |
| Arcellx Common Stock (ACLX) | 3.8 | $127M | 4.0M | 31.62 | |
| Amylyx Pharmaceuticals (AMLX) | 3.1 | $105M | 4.9M | 21.57 | |
| Iovance Biotherapeutics (IOVA) | 3.0 | $99M | 14M | 7.04 | |
| Aldeyra Therapeutics (ALDX) | 2.9 | $95M | 11M | 8.39 | |
| Inhibrx (INBX) | 2.8 | $94M | 3.6M | 25.96 | |
| Nuvalent Inc-a (NUVL) | 2.8 | $93M | 2.2M | 42.17 | |
| Akero Therapeutics (AKRO) | 2.7 | $91M | 1.9M | 46.69 | |
| Vaxcyte (PCVX) | 2.4 | $81M | 1.6M | 49.94 | |
| Meiragtx Holdings (MGTX) | 2.3 | $76M | 11M | 6.72 | |
| Apellis Pharmaceuticals (APLS) | 2.2 | $74M | 812k | 91.10 | |
| Madrigal Pharmaceuticals (MDGL) | 2.1 | $70M | 303k | 231.00 | |
| Reata Pharmaceuticals Cl A | 2.0 | $68M | 670k | 101.96 | |
| Treace Med Concepts (TMCI) | 1.7 | $57M | 2.2M | 25.58 | |
| Lyra Therapeutics (LYRA) | 1.6 | $52M | 13M | 4.11 | |
| Vir Biotechnology (VIR) | 1.4 | $48M | 2.0M | 24.53 | |
| Immunovant (IMVT) | 1.4 | $48M | 2.5M | 18.97 | |
| Xenon Pharmaceuticals (XENE) | 1.4 | $47M | 1.2M | 38.50 | |
| Adma Biologics (ADMA) | 1.3 | $44M | 12M | 3.69 | |
| Rapt Therapeutics (RAPT) | 1.3 | $43M | 2.3M | 18.70 | |
| Miragen Therapeutics (VRDN) | 1.3 | $42M | 1.8M | 23.79 | |
| Medtronic SHS (MDT) | 1.2 | $41M | 467k | 88.10 | |
| Cymabay Therapeutics | 1.2 | $41M | 3.7M | 10.95 | |
| Protagonist Therapeutics (PTGX) | 1.2 | $41M | 1.5M | 27.62 | |
| Springworks Therapeutics (SWTX) | 1.2 | $40M | 1.5M | 26.22 | |
| Immatics SHS (IMTX) | 1.2 | $40M | 3.5M | 11.54 | |
| Acrivon Therapeutics Common Stock (ACRV) | 1.2 | $39M | 3.0M | 12.96 | |
| Nautilus Biotechnology (NAUT) | 1.1 | $35M | 9.1M | 3.87 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.1 | $35M | 1.9M | 18.02 | |
| Disc Medicine (IRON) | 1.0 | $33M | 743k | 44.40 | |
| Roivant Sciences SHS (ROIV) | 0.9 | $32M | 3.1M | 10.08 | |
| Cogent Biosciences (COGT) | 0.9 | $32M | 2.7M | 11.84 | |
| Harmony Biosciences Hldgs In (HRMY) | 0.9 | $31M | 891k | 35.19 | |
| Bridgebio Pharma (BBIO) | 0.9 | $30M | 1.7M | 17.20 | |
| Establishment Labs Holdings Ord (ESTA) | 0.9 | $29M | 425k | 68.61 | |
| Verrica Pharmaceuticals (VRCA) | 0.9 | $29M | 5.0M | 5.77 | |
| Illumina (ILMN) | 0.8 | $27M | 145k | 187.49 | |
| Argenx Se Sponsored Adr (ARGX) | 0.8 | $27M | 69k | 389.73 | |
| Relay Therapeutics (RLAY) | 0.7 | $24M | 1.9M | 12.56 | |
| Tarsus Pharmaceuticals (TARS) | 0.7 | $23M | 1.3M | 18.07 | |
| Rocket Pharmaceuticals (RCKT) | 0.7 | $23M | 1.2M | 19.87 | |
| BioMarin Pharmaceutical (BMRN) | 0.7 | $23M | 263k | 86.68 | |
| Zymeworks Del (ZYME) | 0.6 | $21M | 2.4M | 8.64 | |
| Cabaletta Bio (CABA) | 0.6 | $20M | 1.5M | 12.91 | |
| Outset Med (OM) | 0.6 | $20M | 902k | 21.87 | |
| Natera (NTRA) | 0.6 | $20M | 405k | 48.66 | |
| Axsome Therapeutics (AXSM) | 0.6 | $20M | 272k | 71.86 | |
| Solid Biosciences Com New (SLDB) | 0.5 | $18M | 3.5M | 5.24 | |
| Astria Therapeutics (ATXS) | 0.5 | $18M | 2.2M | 8.33 | |
| CryoLife (AORT) | 0.5 | $16M | 931k | 17.19 | |
| Biomea Fusion (BMEA) | 0.5 | $16M | 716k | 21.95 | |
| Intra Cellular Therapies (ITCI) | 0.5 | $16M | 246k | 63.32 | |
| Mirum Pharmaceuticals (MIRM) | 0.5 | $16M | 602k | 25.87 | |
| Tactile Systems Technology, In (TCMD) | 0.4 | $15M | 602k | 24.93 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.4 | $14M | 2.1M | 7.00 | |
| Athira Pharma (ATHA) | 0.4 | $14M | 4.8M | 2.95 | |
| Axogen (AXGN) | 0.4 | $13M | 1.5M | 9.13 | |
| Fusion Pharmaceuticals (FUSN) | 0.4 | $13M | 2.8M | 4.67 | |
| Prothena Corp SHS (PRTA) | 0.4 | $13M | 185k | 68.28 | |
| Caremax Com Cl A | 0.4 | $12M | 3.8M | 3.11 | |
| Soleno Therapeutics (SLNO) | 0.3 | $9.5M | 2.2M | 4.29 | |
| Neurocrine Biosciences (NBIX) | 0.3 | $9.4M | 100k | 94.30 | |
| Terns Pharmaceuticals Put Option (TERN) | 0.3 | $9.4M | 1.1M | 8.75 | |
| Sarepta Therapeutics (SRPT) | 0.3 | $9.3M | 81k | 114.52 | |
| Biohaven (BHVN) | 0.2 | $7.7M | 321k | 23.92 | |
| Viking Therapeutics (VKTX) | 0.2 | $7.2M | 441k | 16.21 | |
| X4 Pharmaceuticals (XFOR) | 0.2 | $6.9M | 3.5M | 1.94 | |
| Verona Pharma Sponsored Ads Call Option (VRNA) | 0.2 | $6.6M | 4.9M | 1.35 | |
| Iveric Bio | 0.2 | $6.6M | 168k | 39.34 | |
| Landos Biopharma Com New (LABP) | 0.2 | $6.3M | 1.5M | 4.21 | |
| Tyra Biosciences (TYRA) | 0.2 | $6.1M | 360k | 17.03 | |
| Nanobiotix Sponsored Ads (NBTX) | 0.2 | $5.4M | 1.1M | 5.07 | |
| Vbi Vaccines Inc Cda Com New (VBIV) | 0.1 | $4.5M | 1.4M | 3.29 | |
| Acelyrin (SLRN) | 0.1 | $4.2M | 200k | 20.90 | |
| Somalogic Class A Com | 0.1 | $3.5M | 1.5M | 2.31 | |
| Mirati Therapeutics Call Option | 0.1 | $3.2M | 919k | 3.45 | |
| Kronos Bio (KRON) | 0.1 | $3.0M | 1.8M | 1.72 | |
| Quanterix Ord (QTRX) | 0.1 | $2.9M | 130k | 22.55 | |
| Envveno Medical (NVNO) | 0.1 | $2.4M | 782k | 3.08 | |
| Singular Genomics Systems In (OMIC) | 0.1 | $2.0M | 2.4M | 0.83 | |
| Leap Therapeutics Com New (LPTX) | 0.1 | $1.8M | 587k | 3.13 | |
| Arcutis Biotherapeutics Put Option (ARQT) | 0.0 | $1.4M | 300k | 4.72 | |
| Travere Therapeutics (TVTX) | 0.0 | $1.4M | 91k | 15.36 | |
| Point Biopharma Global Put Option | 0.0 | $675k | 500k | 1.35 | |
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 0.0 | $138k | 150k | 0.92 | |
| Female Health (VERU) | 0.0 | $107k | 90k | 1.19 | |
| Motus Gi Hldgs Com New | 0.0 | $60k | 90k | 0.67 | |
| Eqrx *w Exp 12/17/202 | 0.0 | $43k | 250k | 0.17 | |
| Caremax *w Exp 06/08/202 (CMAXW) | 0.0 | $23k | 60k | 0.39 | |
| Bioxcel Therapeutics Call Option (BTAI) | 0.0 | $11k | 440k | 0.03 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $10k | 167k | 0.06 |
